Advancing Novel Treatments for Patients with Muscle Disease
Nonclinical Development - Partnered with Astellas
Myotonic Dystrophy Type 1
Genetic Muscular Dystrophy
New Hope for Patients with Muscle and Heart Disease
Kate Therapeutics is a privately-held company with experienced leadership, a world-class scientific advisory team, and leading investor partners.